trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['pan-tumor', 'enhertu', '$dsnky', 'daiichi', '$azn', 'astrazeneca']
$azn $dsnky asco: astrazeneca, daiichi's enhertu delivers 'very compelling' pan-tumor activity, experts say 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities